Ask
Dr. Brown.

A patient asked me recently if getting on a GLP-1 meant giving up on doing the work. It's a fair question, and I hear it often. GLP-1 medications like semaglutide work by reducing appetite, slowing gastric emptying, and improving insulin sensitivity. For the right patient, they can be genuinely transformative. But they are a tool, not a finish line. The patients I see doing best long-term are the ones using medication as a bridge, not a replacement. Movement, sleep, nutrition, and stress management still matter. They will always matter. A GLP-1 doesn't change your relationship with your body. That part still takes work, and it's worth doing. If you're considering this class of medication, the conversation starts with your full picture, not just a number on a scale.

Someone asked me what the single most underutilized tool in primary care is. I give the same answer every time: sleep. We have spent decades treating the symptoms of poor sleep while undervaluing sleep itself. Chronic sleep deprivation is linked to elevated cortisol, insulin resistance, impaired immune response, mood dysregulation, and significantly increased cardiovascular risk. These are not minor inconveniences. They are clinical outcomes. Seven to nine hours is not a luxury reserved for people with easy schedules. It is a biological requirement. When I work with patients on longevity, sleep is addressed before supplements, before advanced labs, before almost anything else. If you are optimizing everything else but sleeping five hours a night, you are working against yourself.

A patient told me her stress was "just life" and not a medical concern. I respectfully disagreed. I hear this often, and I understand why. We have normalized chronic stress to the point where it no longer registers as a problem. But the body keeps the score, and cortisol does not distinguish between a deadline and a threat. When cortisol stays elevated over time, the effects are measurable: disrupted sleep cycles, increased abdominal fat storage, suppressed immune response, elevated blood pressure, and long-term cardiovascular risk. None of that is abstract. All of it shows up in bloodwork and in how patients feel day to day. Managing stress is not soft medicine. It is one of the most important things I can help a patient work on. If you have been dismissing yours, it may be time to bring it into the conversation.

Peptides come up in my conversations constantly right now, and the questions are good ones. Peptide therapy refers to the use of specific amino acid sequences that act as signaling molecules in the body. Depending on the peptide, the targets can range from growth hormone secretion and tissue repair to immune modulation and cognitive function. BPC-157, for example, has shown promising data in tissue healing. Others in circulation have far less clinical backing. This is an area where the wellness industry has moved faster than the research, and patients are navigating it largely on their own. My approach is to evaluate each peptide on the strength of its evidence and on whether it makes sense for that individual patient's goals and history. If you're curious about peptide therapy, I'd encourage you to bring it to your physician rather than starting independently. The conversation is worth having.

A patient in her 60s asked if creatine was just for bodybuilders. It's a reasonable assumption given how it has been marketed, but the research tells a different story. Creatine monohydrate is one of the most studied supplements available, with decades of safety data and a growing body of evidence supporting its use well beyond athletic performance. For older adults especially, creatine has shown benefits in preserving lean muscle mass, supporting bone density, and improving cognitive function, particularly memory and processing speed. Sarcopenia, the age-related loss of muscle, is one of the strongest predictors of functional decline. Creatine is one of the few supplements that meaningfully addresses it. Three to five grams daily is the standard dose and is well-tolerated across most populations. If you have been dismissing it as a gym supplement, it may be worth revisiting.

A new patient once asked me what made concierge medicine different. I told him: we don't wait for problems. Traditional primary care is largely structured around acute concerns. You come in when something is wrong, we address it, you leave. That model serves a purpose, but it misses the wider picture almost by design. Preventive medicine starts with understanding your baseline. Your family history, your inflammatory markers, your hormone levels, your cardiovascular risk profile. It means having enough time in an appointment to ask the questions that fall outside the chief complaint. It means knowing you well enough that a subtle change registers before it becomes a crisis. The goal of what I do is to help patients stay out of the reactive model as long as possible. That takes intention, time, and a relationship built on more than a fifteen-minute visit.

More patients are asking about alcohol than ever before, and younger ones especially are quietly stepping back from it. This is one of the more meaningful cultural shifts I have observed in recent years. A generation that grew up with "a glass of wine is good for your heart" is now looking at updated research and making different choices, and the science supports the reconsideration. The evidence for cardiovascular benefit from moderate alcohol has not held up under more rigorous analysis. What we do see clearly is that alcohol disrupts sleep architecture, elevates cortisol, strains liver function, affects estrogen metabolism, and carries a measurable association with several cancers even at moderate consumption levels. As for THC beverages, which are increasingly popular as an alternative, the honest answer is that the long-term research is still limited. They sidestep alcohol's specific risks, but they are not without their own considerations, particularly around frequency of use, cognitive effects, and individual response. Anyone substituting regularly is worth a conversation with their physician. The patients making intentional choices about alcohol are doing something genuinely good for their long-term health. That deserves more than just acknowledgment.